DCGI approves India’s first Covid-19 vaccine for human trials
The drug COVAXIN is developed by Bharat Biotech in collaboration with ICMR and NIV
Bharat Biotech becomes the first domestic player to get the green light from drug regulators
The vaccine was developed in Bharat Biotech’s facility at Genome Valley in Hyderabad
Human trials of the vaccine are expected to commence in July
